Test Directory

Test Code
HCGT
Test Name
Beta-hCG, Quantitative (Tumor Marker), CSF
CPT Codes
84702
Expected Turnaround Time
1 day
Clinical Utility

Human chorionic gonadotropin (hCG) is a valuable aid in the management of patients with trophoblastic tumors, nonseminomatous testicular tumors, and seminomas when used in conjunction with information available from the clinical evaluation and other diagnostic procedures. Increased hCG concentrations have also been observed in melanoma, carcinomas of the breast, gastrointestinal tract, lung, and ovaries, and in benign conditions including cirrhosis, duodenal ulcer, and inflammatory bowel disease.

Specimen and Container Info

Specimen Type: Cerebrospinal Fluid

 

Collection Container: Sterile, Non-Additive Container (CSF)

Alternate Collection Container:  Red Top, Plain

Desired Specimen Volume: 0.5 mL

Collection Instructions
  1. Collect CSF specimen via lumbar puncture.
Processing and Submission Instructions
  1. Transfer 0.5 mL of CSF to a sterile aliquot tube.
Transport Instructions

Transport to the laboratory refrigerated. 

Stability Requirements

Room Temperature

5 days

Refrigerated

14 days

Frozen

1 year
Methodology
Quantitative Electrochemilluminescent Immunoassay
Reference Intervals

See patient report.

Limitations

The result cannot be interpreted as absolute evidence of the presence or absence of malignant disease. The result is not interpretable as a tumor marker in pregnant females.

Alternate Names
  • Beta-HCG CSF levels
  • Beta-HCG CSF concentration
  • human chorioinic gonadotropin, CSF
  • Beta-HCG, CSF
Reference Lab
ARUP Laboratories
Testing Schedule
Routine, daily